| Views | |
|---|---|
| Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease | 202 |
| May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | October 2026 | November 2026 | |
|---|---|---|---|---|---|---|---|
| Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease | 8 | 0 | 8 | 17 | 16 | 24 | 5 |
| Views | |
|---|---|
| Gruzdeva_Risk management.pdf | 117 |
| Views | |
|---|---|
| United States | 65 |
| Canada | 16 |
| Germany | 5 |
| China | 4 |
| United Kingdom | 4 |
| India | 3 |
| Japan | 3 |
| South Korea | 3 |
| Vietnam | 3 |
| A2 | 2 |
| Views | |
|---|---|
| Ottawa | 14 |
| Houston | 13 |
| San Francisco | 9 |
| Davidson | 3 |
| Englewood | 3 |
| Hanoi | 3 |
| Indianapolis | 3 |
| Kanda | 3 |
| Palo Alto | 3 |
| Dearborn | 2 |